ZAI LAB LIMITED

(ZLAB)
  Report
Delayed Nasdaq  -  04:00 2022-08-05 pm EDT
45.27 USD   +10.87%
08/03Zai Lab Names Operations Chief
MT
08/03ZAI LAB LTD : Change in Directors or Principal Officers (form 8-K)
AQ
08/03Zai Lab Limited Appoints Joshua Smiley as Chief Operating Officer
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Asian ADRs Move Lower in Wednesday Trading

06/22/2022 | 10:40am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ASLAN PHARMACEUTICALS LIMITED 3.88% 0.529899 Delayed Quote.-52.69%
FOUR SEASONS EDUCATION (CAYMAN) INC. 28.71% 16.5 Delayed Quote.19.57%
ICICI BANK LIMITED -0.15% 836.95 Delayed Quote.13.25%
INFOSYS LIMITED 0.17% 1619.4 Delayed Quote.-14.36%
JIANPU TECHNOLOGY INC. -2.72% 1.79 Delayed Quote.73.79%
PETROCHINA COMPANY LIMITED 0.00% 3.43 Delayed Quote.-1.15%
SIFY TECHNOLOGIES LIMITED 0.86% 2.35 Delayed Quote.-27.24%
TARENA INTERNATIONAL, INC. -1.79% 5.5 Delayed Quote.198.91%
TATA MOTORS LIMITED -0.70% 465.4 End-of-day quote.-3.51%
TUNIU CORPORATION -5.98% 0.9496 Delayed Quote.-2.10%
UNITED MICROELECTRONICS CORPORATION 5.38% 42.15 End-of-day quote.-35.15%
UXIN LIMITED -1.65% 0.6387 Delayed Quote.-59.58%
WIPRO LIMITED 1.02% 439.9 End-of-day quote.-38.49%
ZAI LAB LIMITED 10.87% 45.27 Delayed Quote.-27.97%
All news about ZAI LAB LIMITED
08/03Zai Lab Names Operations Chief
MT
08/03ZAI LAB LTD : Change in Directors or Principal Officers (form 8-K)
AQ
08/03Zai Lab Limited Appoints Joshua Smiley as Chief Operating Officer
CI
07/27SEC Chair Stresses Need to Reach Audit Deal With Chinese Regulators
MT
07/26China’s Securities Watchdog Denies Plan to Help Firms Avoid US Delisting
MT
07/20Deal to Avoid Delisting of 200 Firms in US Bourses Remains Unclear
MT
07/19Zai Lab to Announce Second Quarter 2022 Financial Results on August 9, 2022
GL
07/18SECTOR UPDATE : Health Care Stocks Extending Monday Slide
MT
07/18Zai Lab Rises After Joining Two Stock Connect Programs
MT
07/18SECTOR UPDATE : Health Care Stocks Sinking in Monday Trading
MT
More news
Analyst Recommendations on ZAI LAB LIMITED
More recommendations
Financials (USD)
Sales 2022 224 M - -
Net income 2022 -441 M - -
Net cash 2022 828 M - -
P/E ratio 2022 -9,96x
Yield 2022 -
Capitalization 4 431 M 4 431 M -
EV / Sales 2022 16,1x
EV / Sales 2023 7,74x
Nbr of Employees 1 951
Free-Float 99,8%
Chart ZAI LAB LIMITED
Duration : Period :
Zai Lab Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZAI LAB LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 45,27 $
Average target price 101,05 $
Spread / Average Target 123%
EPS Revisions
Managers and Directors
Ying Du Chairman & Chief Executive Officer
Billy Cho Chief Financial Officer
Ning Xu Executive VP & Head-Clinical Operations
James Yan Chief Operating Officer-Research & Development
Joshua L. Smiley Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZAI LAB LIMITED-27.97%4 431
CSL LIMITED2.07%98 543
SAMSUNG BIOLOGICS CO.,LTD.-0.89%48 860
WUXI BIOLOGICS (CAYMAN) INC.-19.88%40 273
BIOGEN INC.-9.05%31 664
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-19.97%23 596